Статьи и публикации

Случай диагностики болезни Андерсона-Фабри
Случай болезни Фабри у взрослого глазами кардиолога и генетика
Поражение сердца при болезни Фабри: как заподозрить, диагностировать и лечить?

Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry's disease. Ceramide- trihexosidase deficiency. N Engl J Med 1967;276:1163-7

Brady RO, Schiffmann R. Clinical features of and recent advances in therapy for Fabry disease. JAMA 2000;284:2771-5

Brady RO, Tallman JF, Johnson WG, Gal AE, Leahy WR, Quirk JM et al. Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease. N Engl J Med 1973;289:9-14

Brady RO, Uhlendorf BW, Jacobson CB. Fabry's disease: antenatal detection. Science 1971;172:174-5

Branton MH, Schiffmann R, Sabnis SG, Murray GJ, Quirk JM, Altarescu G et al. Natural history of Fabry renal disease: influence of а-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) 2002; 81:122-38

Brown LK, Miller A, Bhuptani A, Sloane MF, Zimmerman MI, Schilero G et al. Pulmonary involvement in Fabry disease. Am J Respir Crit Care Med 1997;155:1004-10

Burda CD, Winder PR. Angiokeratoma corporis diffusum universale (Fabry's disease) in female subjects. Am J Med 1967;42:293-301

Cable WJ, Kolodny EH, Adams RD. Fabry disease: impaired autonomic function. Neurology 1982;32:498-502

Cantor WJ, Daly P, Iwanochko M, Clarke JT, Cusimano RJ, Butany J. Cardiac transplantation for Fabry's disease. Can J Cardiol 1998;14:81-4

Chew E, Ghosh M, McCulloch C. Amiodarone-induced cornea verticillata. Can J Ophthalmol 1982;17:96-9

Chimenti C, Pieroni M, Morgante E, Antuzzi D, Russo A, Russo MA et al. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation 2004;110:1047-53

Chou HH, Hayakawa T, Diaz S, Krings M, Indriati E, Leakey M et al. Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution. Proc Natl Acad Sci USA 2002;99:11736-41

Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994; 23:129-38

Colombi A, Kostyal A, Bracher R, Gloor F, Mazzi R, Tholen H. Angiokeratoma corporis diffusum – Fabry's disease. Helv Med Acta 1967;34:67-83

Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am 2005;34:189-204

Crutchfield KE, Patronas NJ, Dambrosia JM, Frei KP, Banerjee TK, Barton NW et al. Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 1998;50:1746-9

Cybulla M, Schaefer E, Wendt S, Ling H, Krober SM, Hovelborn U et al. Chronic renal failure and proteinuria in adulthood: Fabry disease predominantly affecting the kidneys. Am J Kidney Dis 2005;45:e82-9

Davies JP, Winchester BG, Malcolm S. Sequence variations in the first exon of а-galactosidase A. J Med Genet 1993; 30:658-63

Dean KJ, Sung SS, Sweeley CC. The identification of а-galac- tosidase B from human liver as an а-N-acetylgalacto- saminidase. Biochem Biophys Res Commun 1977;77:1411-17

Deegan P, Baehner AF, Barba-Romero MA, Hughes D, Kampmann C, Beck M. Natural history of Fabry disease in females in the Fabry Outcome Survey. J Med Genet 2006; 43:347-52

Dehout F, Roland D, Treille de Granseigne S, Guillaume B, Van Maldergem L. Relief of gastrointestinal symptoms under enzyme replacement therapy in patients with Fabry disease. J Inherit Metab Dis 2004;27:499-505

Dehout F, Schwarting A, Beck M, Mehta A, Ricci R, Widmer U. Effects of enzyme replacement therapy with agalsidase alfa on glomerular filtration rate in patients with Fabry disease: preliminary data. Acta Paediatr Suppl 2003;92:14-15

Страницы:
←
2
45678910→
из 12